toxicology
- Why are OEL/ADE monographs more expensive for natural health products?
- In reviewing the OEL and ADE equations, I see that the lowest therapeutic dose was used as the point of departure rather than the NOEL (no observed effect level) or NOAEL (no observed adverse effect level)
- ADEs for different routes
- Do I need a dedicated facility for my highly potent active pharmaceutical ingredient?
- What data is needed to prepare an occupational health categorization report?
- Use of the TTC vs calculating an ADE
- Are Affygility Solutions' toxicologists certified?
- What is the procedure for OEL Fastrac updates?
- MultiCASE Q&A
- I want to learn to learn how to calculate ADEs myself?
- Should I panic when an OEL or ADE changes?
- Why do OEL Fastrac monographs not contain the "PDE Determination Strategy" summary sheet contained in the Annex? Does this make the monograph non-compliant?
- Are health based exposure limits required for all products?
- Relationship between minimum therapeutic dose vs. ADE
- How do I apply an OEL Fastrac ADE to a veterinary ADE?
- Rounding conventions of occupational exposure limits and health based exposure limits
- How can I establish an ADE for an early stage compound?
- Do OEL Fastrac monographs include the maximum daily dose (MDD)?
- EuroTox or Society of Toxicology Corporate Memberships
- Will the OEL be higher if I prohibit women in the work area?